Cargando…
Mechanism-based target therapy in primary biliary cholangitis: opportunities before liver cirrhosis?
Primary biliary cholangitis (PBC) is an immune-mediated liver disease characterized by cholestasis, biliary injuries, liver fibrosis, and chronic non-suppurative cholangitis. The pathogenesis of PBC is multifactorial and involves immune dysregulation, abnormal bile metabolism, and progressive fibros...
Autores principales: | Yang, Yushu, He, XiaoSong, Rojas, Manuel, Leung, Patrick S. C., Gao, Lixia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266968/ https://www.ncbi.nlm.nih.gov/pubmed/37325634 http://dx.doi.org/10.3389/fimmu.2023.1184252 |
Ejemplares similares
-
Effect of LncRNA XIST on Immune Cells of Primary Biliary Cholangitis
por: She, Chunhui, et al.
Publicado: (2022) -
Antimitochondrial antibody associated with liver cirrhosis in patients with primary biliary cholangitis
por: Jin, Yujiao, et al.
Publicado: (2023) -
Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis
por: Borchers, Andrea T., et al.
Publicado: (2009) -
Current Concepts in Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis
por: Sclair, Seth N, et al.
Publicado: (2015) -
Gut microbial profile of treatment-naive patients with primary biliary cholangitis
por: Zhou, Yi-jun, et al.
Publicado: (2023)